Jeffrey Bennett, MD
Enriched profileProfessor of Neurology and Professor of Ophthalmology, University of Colorado School of Medicine (also styled: Gertrude Gilden Professor for Neurodegenerative Disease Research) · University of Colorado Anschutz Medical Campus
Jeffrey Bennett is Professor of Neurology and Professor of Ophthalmology, University of Colorado School of Medicine (also styled: Gertrude Gilden Professor for Neurodegenerative Disease Research) at University of Colorado Anschutz Medical Campus. OpenAlex indexes 281 publications with 21,778 citations (h-index 69); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 15 Oct 2026
Jeffrey Bennett, MD, is Professor of Neurology and Professor of Ophthalmology, University of Colorado School of Medicine (also styled: Gertrude Gilden Professor for Neurodegenerative Disease Research) at University of Colorado Anschutz Medical Campus / School of Medicine (Departments of Neurology and Ophthalmology). The public record shows 281 publications with 21,778 citations (h-index 69), centered on Multiple Sclerosis. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 23 companies, 7 NIH-funded awards (1998–2026).
- Most recent indexed publication: 2026 · Neurology(R) neuroimmunology & neuroinflammation
- Top research focus: Multiple Sclerosis
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 23 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 17 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 15 Oct 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Study to Investigate Vagus Nerve Stimulation Paired With Motor Task for Remyelination and Functional Recovery
Sponsor: University of Colorado, Denver
- Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve
Sponsor: Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul
Industry payments
Updated 15 Oct 2026
23 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year202552 payments$41,119openpaymentsdata.cms.gov ↗
- Tanabe Pharma CorporationProgram year202510 payments$16,439openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year202515 payments$13,570openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
54.6%Benzodiazepine25%Diazepam59%Clonazepam41%Part D<11 patientsOther antiepileptics15.7%Topiramate100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
34.3%Corticosteroid34.3%Prednisone100%Part D≥15 patientsCancer & immunology
11.1%Interleukin inhibitors11.1%Enspryng100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 15 Oct 2026
7 NIH research awards on record, funded 1998–2026 per NIH RePORTER. The latest:
- Vagus nerve stimulation to promote remyelination in multiple sclerosis
University of Colorado Denver
FY2026$723,065R61NS141760 - University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.
University of Colorado Denver
FY2026$428,955U24NS133991 - Contribution of antibodies targeting PLP1-anchored membrane domains to multiple sclerosis pathogenesis
University of Colorado Denver
FY2026$411,495R01NS130100
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.
Neurology(R) neuroimmunology & neuroinflammation
Clinical Trial2026 - Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series.
Neurology(R) neuroimmunology & neuroinflammation
Article2026 - Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.
Neurology(R) neuroimmunology & neuroinflammation
Erratum2025 - Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity.
Neurology(R) neuroimmunology & neuroinflammation
Article2025
Online presence
Updated 15 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/jeffrey-bennett-2b49276
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Jeffrey-Bennett-14
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - Doximity
doximity.com/pub/jeffrey-bennett-md-277912b9
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - Doximity
doximity.com/pub/jeffrey-bennett-md-48adbe8d
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - Doximity
doximity.com/pub/jeffrey-bennett-md-5ce6c64c
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
profiles.ucdenver.edu/display/230402
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucdenver.edu ↗ - Other
mscenter.org/2013-02-12-20-12-08/2013-02-12-20-16-27/644-dr-jeffrey-bennett
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mscenter.org ↗ - Other
sumairafoundation.org/welcome-dr-jeffrey-bennett
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sumairafoundation.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 15 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- Directs basic
translational, and clinical research programs on NMOSD, MS, optic neuritis, and MOGAD; maintains active clinical practices in neuro-ophthalmology and neuro-immunology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sumairafoundation.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sumairafoundation.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mscenter.org ↗
Media & interviews
press, podcasts and appearances- Contributor/interviewee
NeurologyLive (clinical neurology news outlet), including discussion of MOGAD diagnosis alongside Dr. Benjamin Greenberg
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurologylive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Bonaca, MD
University of Colorado Anschutz Medical Campus
Satish Garg, MD
University of Colorado Anschutz Medical Campus
Jane Reusch, MD
University of Colorado Anschutz Medical Campus
Kevin Deane, MD
University of Colorado Anschutz Medical Campus
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida